US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avalyn Pharma

33.57

-1.1000-3.17%

Post-market: 33.570.00000.00%19:30 EDT

Volume:132.88K

Turnover:4.55M

Market Cap:1.49B

PE:-14.41

High:35.39

Open:35.15

Low:33.56

Close:34.67

52wk High:40.17

52wk Low:24.15

Shares:44.33M

Float Shares:16.67M

Volume Ratio:0.67

T/O Rate:0.80%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3300

EPS(LYR):-87.7434

ROE:-68.34%

ROA:-41.74%

PB:3.74

PE(LYR):-0.38

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Avalyn Pharma Advances Inhaled Pirfenidone AP01 in Phase 2b MIST Trial for Progressive Pulmonary Fibrosis

One new option listing and two option delistings on August 21st

Avalyn Pharma price target raised to $57 from $53 at Morgan Stanley

Jefferies Sticks to Its Buy Rating for Avalyn Pharma Inc (AVLN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/AVLN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":33.57,"timestamp":1789156800000,"preClose":34.67,"halted":0,"volume":132883,"hourTrading":{"tag":"盘后","latestPrice":33.57,"preClose":33.57,"latestTime":"19:30 EDT","volume":2690,"amount":90303.3,"timestamp":1789169407828,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03172771848860691,"floatShares":16666700,"shares":44333095,"eps":-2.33,"marketStatus":"Market Closed","change":-1.1,"latestTime":"09-11 16:00:00 EDT","open":35.15,"high":35.39,"low":33.56,"amount":4546169.27706,"amplitude":0.052783,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.33,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":34.67,"postHourTrading":{"tag":"盘后","latestPrice":33.57,"preClose":33.57,"latestTime":"19:30 EDT","volume":2690,"amount":90303.3,"timestamp":1789169407828,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.66826,"impliedVol":0.687,"impliedVolPercentile":0.8667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":-87.743381,"volumeRatio":0.66826,"shares":44333095,"dividePrice":0,"high":35.39,"amplitude":0.052783,"preClose":34.67,"low":33.56,"week52Low":24.15,"pbRate":"3.74","week52High":40.17,"institutionHeld":0,"latestPrice":33.57,"eps":-2.33,"divideRate":0,"volume":132883,"delay":0,"ttmEps":-2.33,"open":35.15,"prevYearClose":18,"prevWeekClose":37.39,"prevMonthClose":34.73,"prevQuarterClose":32.92,"fiveDayClose":35.44,"twentyDayClose":36.58,"sixtyDayClose":28.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"AVLN","fiscalQuarterEnding":"2026/06","expectedEps":-1.03,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1781755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-09-10","current":-14.407725,"percent":0.233333,"low":-16.842577,"twenty":-15.666815,"median":-14.123172,"eighty":-13.266645,"high":-8.833116,"avg":-14.346699,"sd":1.30224,"marketCap":1590671448},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-22","current":-13.941602,"twenty":-14.643344,"median":-13.941602,"eighty":-13.42143,"marketCap":1187880255},{"date":"2026-05-29","current":-13.931787,"twenty":-14.643344,"median":-13.931787,"eighty":-13.215324,"marketCap":1187044014},{"date":"2026-06-05","current":-13.244767,"twenty":-14.510847,"median":-13.774754,"eighty":-13.102456,"marketCap":1128507148},{"date":"2026-06-12","current":-13.774754,"twenty":-14.471589,"median":-13.774754,"eighty":-13.161343,"marketCap":1173664159},{"date":"2026-06-18","current":-14.383258,"twenty":-14.479441,"median":-13.794383,"eighty":-13.204528,"marketCap":1225511097},{"date":"2026-06-26","current":-13.585419,"twenty":-14.649233,"median":-13.936694,"eighty":-13.238878,"marketCap":1284773093},{"date":"2026-07-02","current":-14.143275,"twenty":-14.655122,"median":-14.03484,"eighty":-13.265378,"marketCap":1337529476},{"date":"2026-07-10","current":-13.557292,"twenty":-14.643344,"median":-13.937009,"eighty":-13.265378,"marketCap":1282113107},{"date":"2026-07-17","current":-12.038425,"twenty":-14.576758,"median":-13.784568,"eighty":-13.15846,"marketCap":1138473879},{"date":"2026-07-24","current":-13.937009,"twenty":-14.519455,"median":-13.774754,"eighty":-13.193732,"marketCap":1318022914},{"date":"2026-07-31","current":-13.740119,"twenty":-14.495144,"median":-13.755125,"eighty":-13.157019,"marketCap":1299403014},{"date":"2026-08-07","current":-15.329303,"twenty":-14.523759,"median":-13.762486,"eighty":-13.165961,"marketCap":1449692206},{"date":"2026-08-14","current":-15.696852,"twenty":-14.725787,"median":-13.774754,"eighty":-13.189862,"marketCap":1621704615},{"date":"2026-08-21","current":-15.932863,"twenty":-15.087944,"median":-13.934398,"eighty":-13.227101,"marketCap":1646087817},{"date":"2026-08-28","current":-15.666815,"twenty":-15.573456,"median":-13.941602,"eighty":-13.249768,"marketCap":1618601298},{"date":"2026-09-04","current":-15.207667,"twenty":-15.433025,"median":-14.088821,"eighty":-13.261019,"marketCap":1571164886},{"date":"2026-09-10","current":-15.396475,"twenty":-15.666815,"median":-14.123172,"eighty":-13.266645,"marketCap":1590671448}],"updateTime":1789195108811},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVLN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662620570","title":"Avalyn Pharma Advances Inhaled Pirfenidone AP01 in Phase 2b MIST Trial for Progressive Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2662620570","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662620570?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601686,"startTime":"0","endTime":"0","summary":"Avalyn Pharma advances inhaled pirfenidone AP01 in Phase 2b MIST trial for progressive pulmonary fibrosisAvalyn Pharma slated two ERS Congress 2026 posters on Sept. 7 in Barcelona, spotlighting patien","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL2B5BVh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014039.USD","IE00BKPKM429.USD","BCDF","LU0314104364.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","BK4112","SG9999014021.USD","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","AVLN","BK4007","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298158","title":"One new option listing and two option delistings on August 21st","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298158","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661298158?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:35","pubTimestamp":1787315738,"startTime":"0","endTime":"0","summary":"New option listings for August 21st include Avalyn Pharma Inc (AVLN). Option delistings effective August 21st include Liberty Broadband (LBRDK) and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/one-new-option-listing-and-two-option-delistings-on-august-21st-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/one-new-option-listing-and-two-option-delistings-on-august-21st-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4561","AVLN","LBRDK","BK4534","BK4007","BK4100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424488","title":"Avalyn Pharma price target raised to $57 from $53 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424488?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:02","pubTimestamp":1786953775,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on Avalyn Pharma (AVLN) to $57 from $53 and keeps an Overweight rating on the shares. Published first...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-price-target-raised-to-57-from-53-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-price-target-raised-to-57-from-53-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165881","title":"Jefferies Sticks to Its Buy Rating for Avalyn Pharma Inc (AVLN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165881?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:45","pubTimestamp":1786632342,"startTime":"0","endTime":"0","summary":"In a report released today, Roger Song from Jefferies maintained a Buy rating on Avalyn Pharma Inc, with a price target of $52.00. Song covers the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-avalyn-pharma-inc-avln-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-avalyn-pharma-inc-avln-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AVLN\",params:#limit:6,delay:false,,,undefined,":[]}}